Blood Coagulation Factor Market is anticipated to grow at a CAGR of 6.89% from 2021 to 2027 globally - Axiom MRC
Date: November 2021
New York, September 2021: Axiom Market Research & Consulting™ added a report on Blood Coagulation Factor Market which includes study on application and geography. The Blood Coagulation Factor Market was projected to grow at a CAGR of 6.89% for the forecast period 2021 to 2027. The global market is estimated and forecasted in terms of revenue (USD Million) generated by the Blood Coagulation Factor Market.
The factors like increasing number of accidents, increasing number of trauma, increase in the diagnosis rate of the blood clotting disorders have been responsible for driving the blood coagulation factor market. The factors such as shortage in plasma and stringent regulatory policies can possibly hamper the blood coagulation factor market across the globe. The covid-19 also affected the blood coagulation factor market in some manner.
The report analyses the blood coagulation factor market based on the segments including product type, end users and geography. By product type, the blood coagulation factor market includes blood products and non-plasma derived coagulation factor. By end user, the blood coagulation factor market includes hospital, medical centre, and research institute. By geography, the blood coagulation factor market is studies across the regions such as North America, Europe, Asia Pacific and Rest of the World.
The blood products of product type segment have been dominating the blood coagulation factor market
The blood products of the product type have been dominating the blood coagulation factor market as they are used for the supply of plasma, as plasma contains many coagulating factors that help in the process of haemostasis.
The hospitals end user segments is estimated to lead the blood coagulation factor market
The hospitals are leading the end user segment of the blood coagulation market as there is high flow of the patients, who met an accident or suffering from trauma and during the time, the hospital have high requirements of the blood coagulation factors.
The region of North America is dominating the blood coagulation factor market during the forecast period
North America is dominating region in the blood coagulation factor market as it has technological advancements in the healthcare industry along with great healthcare facilities.
The key players in blood coagulation factor market are Baxter International Inc, Bayer AG, Grifols International SA, Kedrion S.p.A, CSL Ltd. Inc., Novo Nordisk A/S, Octapharma AG, F. Hoffmann-La Roche Ltd, Siemens AG, Thermo Fisher Scientific Inc. are analysed among the others.